ALLEGAN (WWJ) --Perrigo Co. (NYSE: PRGO) announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent ...
Perrigo announced that the FDA has approved its abbreviated new drug application (ANDA) for Nitroglycerin Lingual Spray, the generic version of Shionogi’s Nitrolingual Pumpspray. RELATED: ...
Dec. 1, 2004 -- The U.S. Food and Drug Administration (FDA) approved in September revisions to safety labeling to advise healthcare professionals of the following changes: use of nalidixic acid may be ...
Perrigo Company PRGO today announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent to ...
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results